National Round The Clock Hot Line
1-888-365-4458(US)  44-808-111-0143(EU)
86-108-294-5717(AS)
go to cart
1 2 3 4 5

Email Subscribe


Your Position:Home > Medical > Global Biosimilar Monoclonal Antibodies Sales Market Report 2018

Global Biosimilar Monoclonal Antibodies Sales Market Report 2018

Goods_sn:zhaopeihong-gz1

Publishers:QYResearch

Numbers:Share

Price:

License: single license enterprise license

Global Biosimilar Monoclonal Antibodies Sales Market Report 2018

Hard Copy: 4000 USD
PDF Copy (single user): 4000 USD
Enterprise wide License: 8000 USD
Pages: 110
Tables and Figures: 130
Published Date: June 2018
Publisher: QYR Pharma & Healthcare Research Center
Contact: Tel: 1-6262952442; 86-10-82945717; Email: sales@qyresearch.com

Summary

This report studies the global Biosimilar Monoclonal Antibodies market status and forecast, categorizes the global Biosimilar Monoclonal Antibodies market size (value & volume) by key players, type, application, and region. This report focuses on the top players in North America, Europe, China, Japan, Southeast Asia India and Other regions (Middle East & Africa, Central & South America).

A monoclonal antibody is a type of protein made in the laboratory that can bind to substances in the body, including cancer cells. A monoclonal antibody is made so that it binds to only one substance to treat different types of cancer. There are several types of monoclonal antibodies that are being used to treat certain types of cancer. Laboratory production of monoclonal antibodies is produced from clones of only one cell which means that every monoclonal antibody produced by the cell is the same due to which they are called as biosimilar monoclonal antibodies. Each monoclonal antibody recognizes one particular protein. They work in different ways depending on the protein they are targeting, hence different monoclonal antibodies are required to be made to target different types of cancer.
The global Biosimilar Monoclonal Antibodies market is valued at xx million US$ in 2017 and will reach xx million US$ by the end of 2025, growing at a CAGR of 42.0% during 2018-2025.

The major players covered in this report
    Pfizer, Inc.
    Novartis AG
    Reliance Life Sciences
    Allergan plc
    Coherus BioSciences, Inc.
    Biocon
    Dr. Reddy's Laboratories Ltd.
    Boehringer Ingelheim GmbH
    BioXpress Therapeutics SA
    Intas Pharmaceuticals Limited
    BIOCAD
    Genor BioPharma Co. Ltd
    Celltrion, Inc.

Geographically, this report studies the key regions, focuses on product sales, value, market share and growth opportunity in these regions, covering
    United States
    Europe
    China
    Japan
    Southeast Asia
    India

We can also provide the customized separate regional or country-level reports, for the following regions:
    North America
        United States
        Canada
        Mexico
    Asia-Pacific
        China
        India
        Japan
        South Korea
        Australia
        Indonesia
        Singapore
        Rest of Asia-Pacific
    Europe
        Germany
        France
        UK
        Italy
        Spain
        Russia
        Rest of Europe
    Central & South America
        Brazil
        Argentina
        Rest of South America
    Middle East & Africa
        Saudi Arabia
        Turkey
        Rest of Middle East & Africa

On the basis of product, this report displays the production, revenue, price, market share and growth rate of each type, primarily split into
    Rituximab
    Infliximab
    Abciximab
    Trastuzumab
    Adalimumab
    Bevacizumab
On the basis on the end users/applications, this report focuses on the status and outlook for major applications/end users, sales volume, market share and growth rate for each application, including
    Oncology
    Chronic and Autoimmune Diseases
    Growth Hormone Deficiency
    Infectious Diseases
    Others

The study objectives of this report are:
    To analyze and study the global Biosimilar Monoclonal Antibodies sales, value, status (2013-2017) and forecast (2018-2025);
    To analyze the top players in North America, Europe, China, Japan, Southeast Asia and India, to study the sales, value and market share of top players in these regions.
    Focuses on the key Biosimilar Monoclonal Antibodies players, to study the sales, value, market share and development plans in future.
    Focuses on the global key manufacturers, to define, describe and analyze the market competition landscape, SWOT analysis.
    To define, describe and forecast the market by type, application and region.
    To analyze the global and key regions market potential and advantage, opportunity and challenge, restraints and risks.
    To identify significant trends and factors driving or inhibiting the market growth.
    To analyze the opportunities in the market for stakeholders by identifying the high growth segments.
    To strategically analyze each submarket with respect to individual growth trend and their contribution to the market
    To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market
    To strategically profile the key players and comprehensively analyze their growth strategies.

In this study, the years considered to estimate the market size of Biosimilar Monoclonal Antibodies are as follows:
    History Year: 2013-2017
    Base Year: 2017
    Estimated Year: 2018
    Forecast Year 2018 to 2025

For the data information by region, company, type and application, 2017 is considered as the base year. Whenever data information was unavailable for the base year, the prior year has been considered.

Key Stakeholders
Biosimilar Monoclonal Antibodies Manufacturers
Biosimilar Monoclonal Antibodies Distributors/Traders/Wholesalers
Biosimilar Monoclonal Antibodies Subcomponent Manufacturers
Industry Association
Downstream Vendors

Available Customizations
With the given market data, QYResearch offers customizations according to the company's specific needs. The following customization options are available for the report:
Regional and country-level analysis of the Biosimilar Monoclonal Antibodies market, by end-use.
Detailed analysis and profiles of additional market players.


Table of Contents

Global Biosimilar Monoclonal Antibodies Sales Market Report 2018
1 Biosimilar Monoclonal Antibodies Market Overview
    1.1 Product Overview and Scope of Biosimilar Monoclonal Antibodies
    1.2 Classification of Biosimilar Monoclonal Antibodies by Product Category
        1.2.1 Global Biosimilar Monoclonal Antibodies Market Size (Sales) Comparison by Type (2013-2025)
        1.2.2 Global Biosimilar Monoclonal Antibodies Market Size (Sales) Market Share by Type (Product Category) in 2017
        1.2.3 Rituximab
        1.2.4 Infliximab
        1.2.5 Abciximab
        1.2.6 Trastuzumab
        1.2.7 Adalimumab
        1.2.8 Bevacizumab
    1.3 Global Biosimilar Monoclonal Antibodies Market by Application/End Users
        1.3.1 Global Biosimilar Monoclonal Antibodies Sales (Volume) and Market Share Comparison by Application (2013-2025)
        1.3.1 Oncology
        1.3.2 Chronic and Autoimmune Diseases
        1.3.3 Growth Hormone Deficiency
        1.3.4 Infectious Diseases
        1.3.5 Others
    1.4 Global Biosimilar Monoclonal Antibodies Market by Region
        1.4.1 Global Biosimilar Monoclonal Antibodies Market Size (Value) Comparison by Region (2013-2025)
        1.4.2 United States Biosimilar Monoclonal Antibodies Status and Prospect (2013-2025)
        1.4.3 Europe Biosimilar Monoclonal Antibodies Status and Prospect (2013-2025)
        1.4.4 China Biosimilar Monoclonal Antibodies Status and Prospect (2013-2025)
        1.4.5 Japan Biosimilar Monoclonal Antibodies Status and Prospect (2013-2025)
        1.4.6 Southeast Asia Biosimilar Monoclonal Antibodies Status and Prospect (2013-2025)
        1.4.7 India Biosimilar Monoclonal Antibodies Status and Prospect (2013-2025)
    1.5 Global Market Size (Value and Volume) of Biosimilar Monoclonal Antibodies (2013-2025)
        1.5.1 Global Biosimilar Monoclonal Antibodies Sales and Growth Rate (2013-2025)
        1.5.2 Global Biosimilar Monoclonal Antibodies Revenue and Growth Rate (2013-2025)

2 Global Biosimilar Monoclonal Antibodies Competition by Players/Suppliers, Type and Application
     2.1 Global Biosimilar Monoclonal Antibodies Market Competition by Players/Suppliers
        2.1.1 Global Biosimilar Monoclonal Antibodies Sales and Market Share of Key Players/Suppliers (2013-2018)
        2.1.2 Global Biosimilar Monoclonal Antibodies Revenue and Share by Players/Suppliers (2013-2018)
    2.2 Global Biosimilar Monoclonal Antibodies (Volume and Value) by Type
        2.2.1 Global Biosimilar Monoclonal Antibodies Sales and Market Share by Type (2013-2018)
        2.2.2 Global Biosimilar Monoclonal Antibodies Revenue and Market Share by Type (2013-2018)
    2.3 Global Biosimilar Monoclonal Antibodies (Volume and Value) by Region
        2.3.1 Global Biosimilar Monoclonal Antibodies Sales and Market Share by Region (2013-2018)
        2.3.2 Global Biosimilar Monoclonal Antibodies Revenue and Market Share by Region (2013-2018)
    2.4 Global Biosimilar Monoclonal Antibodies (Volume) by Application

3 United States Biosimilar Monoclonal Antibodies (Volume, Value and Sales Price)
    3.1 United States Biosimilar Monoclonal Antibodies Sales and Value (2013-2018)
        3.1.1 United States Biosimilar Monoclonal Antibodies Sales and Growth Rate (2013-2018)
        3.1.2 United States Biosimilar Monoclonal Antibodies Revenue and Growth Rate (2013-2018)
        3.1.3 United States Biosimilar Monoclonal Antibodies Sales Price Trend (2013-2018)
    3.2 United States Biosimilar Monoclonal Antibodies Sales Volume and Market Share by Players (2013-2018)
    3.3 United States Biosimilar Monoclonal Antibodies Sales Volume and Market Share by Type (2013-2018)
    3.4 United States Biosimilar Monoclonal Antibodies Sales Volume and Market Share by Application (2013-2018)

4 Europe Biosimilar Monoclonal Antibodies (Volume, Value and Sales Price)
    4.1 Europe Biosimilar Monoclonal Antibodies Sales and Value (2013-2018)
        4.1.1 Europe Biosimilar Monoclonal Antibodies Sales and Growth Rate (2013-2018)
        4.1.2 Europe Biosimilar Monoclonal Antibodies Revenue and Growth Rate (2013-2018)
        4.1.3 Europe Biosimilar Monoclonal Antibodies Sales Price Trend (2013-2018)
    4.2 Europe Biosimilar Monoclonal Antibodies Sales Volume and Market Share by Players (2013-2018)
    4.3 Europe Biosimilar Monoclonal Antibodies Sales Volume and Market Share by Type (2013-2018)
    4.4 Europe Biosimilar Monoclonal Antibodies Sales Volume and Market Share by Application (2013-2018)

5 China Biosimilar Monoclonal Antibodies (Volume, Value and Sales Price)
    5.1 China Biosimilar Monoclonal Antibodies Sales and Value (2013-2018)
        5.1.1 China Biosimilar Monoclonal Antibodies Sales and Growth Rate (2013-2018)
        5.1.2 China Biosimilar Monoclonal Antibodies Revenue and Growth Rate (2013-2018)
        5.1.3 China Biosimilar Monoclonal Antibodies Sales Price Trend (2013-2018)
    5.2 China Biosimilar Monoclonal Antibodies Sales Volume and Market Share by Players (2013-2018)
    5.3 China Biosimilar Monoclonal Antibodies Sales Volume and Market Share by Type (2013-2018)
    5.4 China Biosimilar Monoclonal Antibodies Sales Volume and Market Share by Application (2013-2018)

6 Japan Biosimilar Monoclonal Antibodies (Volume, Value and Sales Price)
    6.1 Japan Biosimilar Monoclonal Antibodies Sales and Value (2013-2018)
        6.1.1 Japan Biosimilar Monoclonal Antibodies Sales and Growth Rate (2013-2018)
        6.1.2 Japan Biosimilar Monoclonal Antibodies Revenue and Growth Rate (2013-2018)
        6.1.3 Japan Biosimilar Monoclonal Antibodies Sales Price Trend (2013-2018)
    6.2 Japan Biosimilar Monoclonal Antibodies Sales Volume and Market Share by Players (2013-2018)
    6.3 Japan Biosimilar Monoclonal Antibodies Sales Volume and Market Share by Type (2013-2018)
    6.4 Japan Biosimilar Monoclonal Antibodies Sales Volume and Market Share by Application (2013-2018)

7 Southeast Asia Biosimilar Monoclonal Antibodies (Volume, Value and Sales Price)
    7.1 Southeast Asia Biosimilar Monoclonal Antibodies Sales and Value (2013-2018)
        7.1.1 Southeast Asia Biosimilar Monoclonal Antibodies Sales and Growth Rate (2013-2018)
        7.1.2 Southeast Asia Biosimilar Monoclonal Antibodies Revenue and Growth Rate (2013-2018)
        7.1.3 Southeast Asia Biosimilar Monoclonal Antibodies Sales Price Trend (2013-2018)
    7.2 Southeast Asia Biosimilar Monoclonal Antibodies Sales Volume and Market Share by Players (2013-2018)
    7.3 Southeast Asia Biosimilar Monoclonal Antibodies Sales Volume and Market Share by Type (2013-2018)
    7.4 Southeast Asia Biosimilar Monoclonal Antibodies Sales Volume and Market Share by Application (2013-2018)

8 India Biosimilar Monoclonal Antibodies (Volume, Value and Sales Price)
    8.1 India Biosimilar Monoclonal Antibodies Sales and Value (2013-2018)
        8.1.1 India Biosimilar Monoclonal Antibodies Sales and Growth Rate (2013-2018)
        8.1.2 India Biosimilar Monoclonal Antibodies Revenue and Growth Rate (2013-2018)
        8.1.3 India Biosimilar Monoclonal Antibodies Sales Price Trend (2013-2018)
    8.2 India Biosimilar Monoclonal Antibodies Sales Volume and Market Share by Players (2013-2018)
    8.3 India Biosimilar Monoclonal Antibodies Sales Volume and Market Share by Type (2013-2018)
    8.4 India Biosimilar Monoclonal Antibodies Sales Volume and Market Share by Application (2013-2018)

9 Global Biosimilar Monoclonal Antibodies Players/Suppliers Profiles and Sales Data
    9.1 Pfizer, Inc.
        9.1.1 Company Basic Information, Manufacturing Base and Competitors
        9.1.2 Biosimilar Monoclonal Antibodies Product Category, Application and Specification
            9.1.2.1 Product A
            9.1.2.2 Product B
        9.1.3 Pfizer, Inc. Biosimilar Monoclonal Antibodies Sales, Revenue, Price and Gross Margin (2013-2018)
        9.1.4 Main Business/Business Overview
    9.2 Novartis AG
        9.2.1 Company Basic Information, Manufacturing Base and Competitors
        9.2.2 Biosimilar Monoclonal Antibodies Product Category, Application and Specification
            9.2.2.1 Product A
            9.2.2.2 Product B
        9.2.3 Novartis AG Biosimilar Monoclonal Antibodies Sales, Revenue, Price and Gross Margin (2013-2018)
        9.2.4 Main Business/Business Overview
    9.3 Reliance Life Sciences
        9.3.1 Company Basic Information, Manufacturing Base and Competitors
        9.3.2 Biosimilar Monoclonal Antibodies Product Category, Application and Specification
            9.3.2.1 Product A
            9.3.2.2 Product B
        9.3.3 Reliance Life Sciences Biosimilar Monoclonal Antibodies Sales, Revenue, Price and Gross Margin (2013-2018)
        9.3.4 Main Business/Business Overview
    9.4 Allergan plc
        9.4.1 Company Basic Information, Manufacturing Base and Competitors
        9.4.2 Biosimilar Monoclonal Antibodies Product Category, Application and Specification
            9.4.2.1 Product A
            9.4.2.2 Product B
        9.4.3 Allergan plc Biosimilar Monoclonal Antibodies Sales, Revenue, Price and Gross Margin (2013-2018)
        9.4.4 Main Business/Business Overview
    9.5 Coherus BioSciences, Inc.
        9.5.1 Company Basic Information, Manufacturing Base and Competitors
        9.5.2 Biosimilar Monoclonal Antibodies Product Category, Application and Specification
            9.5.2.1 Product A
            9.5.2.2 Product B
        9.5.3 Coherus BioSciences, Inc. Biosimilar Monoclonal Antibodies Sales, Revenue, Price and Gross Margin (2013-2018)
        9.5.4 Main Business/Business Overview
    9.6 Biocon
        9.6.1 Company Basic Information, Manufacturing Base and Competitors
        9.6.2 Biosimilar Monoclonal Antibodies Product Category, Application and Specification
            9.6.2.1 Product A
            9.6.2.2 Product B
        9.6.3 Biocon Biosimilar Monoclonal Antibodies Sales, Revenue, Price and Gross Margin (2013-2018)
        9.6.4 Main Business/Business Overview
    9.7 Dr. Reddy's Laboratories Ltd.
        9.7.1 Company Basic Information, Manufacturing Base and Competitors
        9.7.2 Biosimilar Monoclonal Antibodies Product Category, Application and Specification
            9.7.2.1 Product A
            9.7.2.2 Product B
        9.7.3 Dr. Reddy's Laboratories Ltd. Biosimilar Monoclonal Antibodies Sales, Revenue, Price and Gross Margin (2013-2018)
        9.7.4 Main Business/Business Overview
    9.8 Boehringer Ingelheim GmbH
        9.8.1 Company Basic Information, Manufacturing Base and Competitors
        9.8.2 Biosimilar Monoclonal Antibodies Product Category, Application and Specification
            9.8.2.1 Product A
            9.8.2.2 Product B
        9.8.3 Boehringer Ingelheim GmbH Biosimilar Monoclonal Antibodies Sales, Revenue, Price and Gross Margin (2013-2018)
        9.8.4 Main Business/Business Overview
    9.9 BioXpress Therapeutics SA
        9.9.1 Company Basic Information, Manufacturing Base and Competitors
        9.9.2 Biosimilar Monoclonal Antibodies Product Category, Application and Specification
            9.9.2.1 Product A
            9.9.2.2 Product B
        9.9.3 BioXpress Therapeutics SA Biosimilar Monoclonal Antibodies Sales, Revenue, Price and Gross Margin (2013-2018)
        9.9.4 Main Business/Business Overview
    9.10 Intas Pharmaceuticals Limited
        9.10.1 Company Basic Information, Manufacturing Base and Competitors
        9.10.2 Biosimilar Monoclonal Antibodies Product Category, Application and Specification
            9.10.2.1 Product A
            9.10.2.2 Product B
        9.10.3 Intas Pharmaceuticals Limited Biosimilar Monoclonal Antibodies Sales, Revenue, Price and Gross Margin (2013-2018)
        9.10.4 Main Business/Business Overview
    9.11 BIOCAD
    9.12 Genor BioPharma Co. Ltd
    9.13 Celltrion, Inc.

10 Biosimilar Monoclonal Antibodies Maufacturing Cost Analysis
    10.1 Biosimilar Monoclonal Antibodies Key Raw Materials Analysis
        10.1.1 Key Raw Materials
        10.1.2 Price Trend of Key Raw Materials
        10.1.3 Key Suppliers of Raw Materials
        10.1.4 Market Concentration Rate of Raw Materials
    10.2 Proportion of Manufacturing Cost Structure
        10.2.1 Raw Materials
        10.2.2 Labor Cost
        10.2.3 Manufacturing Process Analysis of Biosimilar Monoclonal Antibodies
    10.3 Manufacturing Process Analysis of Biosimilar Monoclonal Antibodies

11 Industrial Chain, Sourcing Strategy and Downstream Buyers
    11.1 Biosimilar Monoclonal Antibodies Industrial Chain Analysis
    11.2 Upstream Raw Materials Sourcing
    11.3 Raw Materials Sources of Biosimilar Monoclonal Antibodies Major Manufacturers in 2017
    11.4 Downstream Buyers

12 Marketing Strategy Analysis, Distributors/Traders
    12.1 Marketing Channel
        12.1.1 Direct Marketing
        12.1.2 Indirect Marketing
        12.1.3 Marketing Channel Development Trend
    12.2 Market Positioning
        12.2.1 Pricing Strategy
        12.2.2 Brand Strategy
        12.2.3 Target Client
    12.3 Distributors/Traders List

13 Market Effect Factors Analysis
    13.1 Technology Progress/Risk
        13.1.1 Substitutes Threat
        13.1.2 Technology Progress in Related Industry
    13.2 Consumer Needs/Customer Preference Change
    13.3 Economic/Political Environmental Change

14 Global Biosimilar Monoclonal Antibodies Market Forecast (2018-2025)
    14.1 Global Biosimilar Monoclonal Antibodies Sales Volume, Revenue and Price Forecast (2018-2025)
     14.1.1 Global Biosimilar Monoclonal Antibodies Sales Volume and Growth Rate Forecast (2018-2025)
     14.1.2 Global Biosimilar Monoclonal Antibodies Revenue and Growth Rate Forecast (2018-2025)
     14.1.3 Global Biosimilar Monoclonal Antibodies Price and Trend Forecast (2018-2025)
    14.2 Global Biosimilar Monoclonal Antibodies Sales Volume, Revenue and Growth Rate Forecast by Region (2018-2025)
     14.2.1 Global Biosimilar Monoclonal Antibodies Sales Volume and Growth Rate Forecast by Regions (2018-2025)
     14.2.2 Global Biosimilar Monoclonal Antibodies Revenue and Growth Rate Forecast by Regions (2018-2025)
     14.2.3 United States Biosimilar Monoclonal Antibodies Sales Volume, Revenue and Growth Rate Forecast (2018-2025)
     14.2.4 Europe Biosimilar Monoclonal Antibodies Sales Volume, Revenue and Growth Rate Forecast (2018-2025)
     14.2.5 China Biosimilar Monoclonal Antibodies Sales Volume, Revenue and Growth Rate Forecast (2018-2025)
     14.2.6 Japan Biosimilar Monoclonal Antibodies Sales Volume, Revenue and Growth Rate Forecast (2018-2025)
     14.2.7 Southeast Asia Biosimilar Monoclonal Antibodies Sales Volume, Revenue and Growth Rate Forecast (2018-2025)
     14.2.8 India Biosimilar Monoclonal Antibodies Sales Volume, Revenue and Growth Rate Forecast (2018-2025)
    14.3 Global Biosimilar Monoclonal Antibodies Sales Volume, Revenue and Price Forecast by Type (2018-2025)
     14.3.1 Global Biosimilar Monoclonal Antibodies Sales Forecast by Type (2018-2025)
     14.3.2 Global Biosimilar Monoclonal Antibodies Revenue Forecast by Type (2018-2025)
     14.3.3 Global Biosimilar Monoclonal Antibodies Price Forecast by Type (2018-2025)
    14.4 Global Biosimilar Monoclonal Antibodies Sales Volume Forecast by Application (2018-2025)

15 Research Findings and Conclusion

16 Appendix
    16.1 Methodology/Research Approach
        16.1.1 Research Programs/Design
        16.1.2 Market Size Estimation
        16.1.3 Market Breakdown and Data Triangulation
    16.2 Data Source
        16.2.1 Secondary Sources
        16.2.2 Primary Sources
    16.3 Disclaimer


List of Tables and Figures

    Figure Product Picture of Biosimilar Monoclonal Antibodies
    Figure Global Biosimilar Monoclonal Antibodies Sales Volume Comparison (K Units) by Type (2013-2025)
    Figure Global Biosimilar Monoclonal Antibodies Sales Volume Market Share by Type (Product Category) in 2017
    Figure Rituximab Product Picture
    Figure Infliximab Product Picture
    Figure Abciximab Product Picture
    Figure Trastuzumab Product Picture
    Figure Adalimumab Product Picture
    Figure Bevacizumab Product Picture
    Figure Global Biosimilar Monoclonal Antibodies Sales Comparison (K Units) by Application (2013-2025)
    Figure Global Sales Market Share of Biosimilar Monoclonal Antibodies by Application in 2017
    Figure Oncology Examples
    Table Key Downstream Customer in Oncology
    Figure Chronic and Autoimmune Diseases Examples
    Table Key Downstream Customer in Chronic and Autoimmune Diseases
    Figure Growth Hormone Deficiency Examples
    Table Key Downstream Customer in Growth Hormone Deficiency
    Figure Infectious Diseases Examples
    Table Key Downstream Customer in Infectious Diseases
    Figure Others Examples
    Table Key Downstream Customer in Others
    Figure Global Biosimilar Monoclonal Antibodies Market Size (Million USD) by Regions (2013-2025)
    Figure United States Biosimilar Monoclonal Antibodies Revenue (Million USD) and Growth Rate (2013-2025)
    Figure Europe Biosimilar Monoclonal Antibodies Revenue (Million USD) and Growth Rate (2013-2025)
    Figure China Biosimilar Monoclonal Antibodies Revenue (Million USD) and Growth Rate (2013-2025)
    Figure Japan Biosimilar Monoclonal Antibodies Revenue (Million USD) and Growth Rate (2013-2025)
    Figure Southeast Asia Biosimilar Monoclonal Antibodies Revenue (Million USD) and Growth Rate (2013-2025)
    Figure India Biosimilar Monoclonal Antibodies Revenue (Million USD) and Growth Rate (2013-2025)
    Figure Global Biosimilar Monoclonal Antibodies Sales Volume (K Units) and Growth Rate (2013-2025)
    Figure Global Biosimilar Monoclonal Antibodies Revenue (Million USD) and Growth Rate (2013-2025)
    Figure Global Market Major Players Biosimilar Monoclonal Antibodies Sales Volume (K Units) (2013-2018)
    Table Global Biosimilar Monoclonal Antibodies Sales (K Units) of Key Players/Suppliers (2013-2018)
    Table Global Biosimilar Monoclonal Antibodies Sales Share by Players/Suppliers (2013-2018)
    Figure 2017 Biosimilar Monoclonal Antibodies Sales Share by Players/Suppliers
    Figure 2017 Biosimilar Monoclonal Antibodies Sales Share by Players/Suppliers
    Figure Global Biosimilar Monoclonal Antibodies Revenue (Million USD) by Players/Suppliers (2013-2018)
    Table Global Biosimilar Monoclonal Antibodies Revenue (Million USD) by Players/Suppliers (2013-2018)
    Table Global Biosimilar Monoclonal Antibodies Revenue Share by Players/Suppliers (2013-2018)
    Table 2017 Global Biosimilar Monoclonal Antibodies Revenue Share by Players
    Table 2017 Global Biosimilar Monoclonal Antibodies Revenue Share by Players
    Table Global Biosimilar Monoclonal Antibodies Sales (K Units) and Market Share by Type (2013-2018)
    Table Global Biosimilar Monoclonal Antibodies Sales Share (K Units) by Type (2013-2018)
    Figure Sales Market Share of Biosimilar Monoclonal Antibodies by Type (2013-2018)
    Figure Global Biosimilar Monoclonal Antibodies Sales Growth Rate by Type (2013-2018)
    Table Global Biosimilar Monoclonal Antibodies Revenue (Million USD) and Market Share by Type (2013-2018)
    Table Global Biosimilar Monoclonal Antibodies Revenue Share by Type (2013-2018)
    Figure Revenue Market Share of Biosimilar Monoclonal Antibodies by Type (2013-2018)
    Figure Global Biosimilar Monoclonal Antibodies Revenue Growth Rate by Type (2013-2018)
    Table Global Biosimilar Monoclonal Antibodies Sales Volume (K Units) and Market Share by Region (2013-2018)
    Table Global Biosimilar Monoclonal Antibodies Sales Share by Region (2013-2018)
    Figure Sales Market Share of Biosimilar Monoclonal Antibodies by Region (2013-2018)
    Figure Global Biosimilar Monoclonal Antibodies Sales Growth Rate by Region in 2017
    Table Global Biosimilar Monoclonal Antibodies Revenue (Million USD) and Market Share by Region (2013-2018)
    Table Global Biosimilar Monoclonal Antibodies Revenue Share (%) by Region (2013-2018)
    Figure Revenue Market Share of Biosimilar Monoclonal Antibodies by Region (2013-2018)
    Figure Global Biosimilar Monoclonal Antibodies Revenue Growth Rate by Region in 2017
    Table Global Biosimilar Monoclonal Antibodies Revenue (Million USD) and Market Share by Region (2013-2018)
    Table Global Biosimilar Monoclonal Antibodies Revenue Share (%) by Region (2013-2018)
    Figure Revenue Market Share of Biosimilar Monoclonal Antibodies by Region (2013-2018)
    Figure Global Biosimilar Monoclonal Antibodies Revenue Market Share by Region in 2017
    Table Global Biosimilar Monoclonal Antibodies Sales Volume (K Units) and Market Share by Application (2013-2018)
    Table Global Biosimilar Monoclonal Antibodies Sales Share (%) by Application (2013-2018)
    Figure Sales Market Share of Biosimilar Monoclonal Antibodies by Application (2013-2018)
    Figure Global Biosimilar Monoclonal Antibodies Sales Market Share by Application (2013-2018)
    Figure United States Biosimilar Monoclonal Antibodies Sales (K Units) and Growth Rate (2013-2018)
    Figure United States Biosimilar Monoclonal Antibodies Revenue (Million USD) and Growth Rate (2013-2018)
    Figure United States Biosimilar Monoclonal Antibodies Sales Price (USD/Unit) Trend (2013-2018)
    Table United States Biosimilar Monoclonal Antibodies Sales Volume (K Units) by Players (2013-2018)
    Table United States Biosimilar Monoclonal Antibodies Sales Volume Market Share by Players (2013-2018)
    Figure United States Biosimilar Monoclonal Antibodies Sales Volume Market Share by Players in 2017
    Table United States Biosimilar Monoclonal Antibodies Sales Volume (K Units) by Type (2013-2018)
    Table United States Biosimilar Monoclonal Antibodies Sales Volume Market Share by Type (2013-2018)
    Figure United States Biosimilar Monoclonal Antibodies Sales Volume Market Share by Type in 2017
    Table United States Biosimilar Monoclonal Antibodies Sales Volume (K Units) by Application (2013-2018)
    Table United States Biosimilar Monoclonal Antibodies Sales Volume Market Share by Application (2013-2018)
    Figure United States Biosimilar Monoclonal Antibodies Sales Volume Market Share by Application in 2017
    Figure Europe Biosimilar Monoclonal Antibodies Sales (K Units) and Growth Rate (2013-2018)
    Figure Europe Biosimilar Monoclonal Antibodies Revenue (Million USD) and Growth Rate (2013-2018)
    Figure Europe Biosimilar Monoclonal Antibodies Sales Price (USD/Unit) Trend (2013-2018)
    Table Europe Biosimilar Monoclonal Antibodies Sales Volume (K Units) by Players (2013-2018)
    Table Europe Biosimilar Monoclonal Antibodies Sales Volume Market Share by Players (2013-2018)
    Figure Europe Biosimilar Monoclonal Antibodies Sales Volume Market Share by Players in 2017
    Table Europe Biosimilar Monoclonal Antibodies Sales Volume (K Units) by Type (2013-2018)
    Table Europe Biosimilar Monoclonal Antibodies Sales Volume Market Share by Type (2013-2018)
    Figure Europe Biosimilar Monoclonal Antibodies Sales Volume Market Share by Type in 2017
    Table Europe Biosimilar Monoclonal Antibodies Sales Volume (K Units) by Application (2013-2018)
    Table Europe Biosimilar Monoclonal Antibodies Sales Volume Market Share by Application (2013-2018)
    Figure Europe Biosimilar Monoclonal Antibodies Sales Volume Market Share by Application in 2017
    Figure China Biosimilar Monoclonal Antibodies Sales (K Units) and Growth Rate (2013-2018)
    Figure China Biosimilar Monoclonal Antibodies Revenue (Million USD) and Growth Rate (2013-2018)
    Figure China Biosimilar Monoclonal Antibodies Sales Price (USD/Unit) Trend (2013-2018)
    Table China Biosimilar Monoclonal Antibodies Sales Volume (K Units) by Players (2013-2018)
    Table China Biosimilar Monoclonal Antibodies Sales Volume Market Share by Players (2013-2018)
    Figure China Biosimilar Monoclonal Antibodies Sales Volume Market Share by Players in 2017
    Table China Biosimilar Monoclonal Antibodies Sales Volume (K Units) by Type (2013-2018)
    Table China Biosimilar Monoclonal Antibodies Sales Volume Market Share by Type (2013-2018)
    Figure China Biosimilar Monoclonal Antibodies Sales Volume Market Share by Type in 2017
    Table China Biosimilar Monoclonal Antibodies Sales Volume (K Units) by Application (2013-2018)
    Table China Biosimilar Monoclonal Antibodies Sales Volume Market Share by Application (2013-2018)
    Figure China Biosimilar Monoclonal Antibodies Sales Volume Market Share by Application in 2017
    Figure Japan Biosimilar Monoclonal Antibodies Sales (K Units) and Growth Rate (2013-2018)
    Figure Japan Biosimilar Monoclonal Antibodies Revenue (Million USD) and Growth Rate (2013-2018)
    Figure Japan Biosimilar Monoclonal Antibodies Sales Price (USD/Unit) Trend (2013-2018)
    Table Japan Biosimilar Monoclonal Antibodies Sales Volume (K Units) by Players (2013-2018)
    Table Japan Biosimilar Monoclonal Antibodies Sales Volume Market Share by Players (2013-2018)
    Figure Japan Biosimilar Monoclonal Antibodies Sales Volume Market Share by Players in 2017
    Table Japan Biosimilar Monoclonal Antibodies Sales Volume (K Units) by Type (2013-2018)
    Table Japan Biosimilar Monoclonal Antibodies Sales Volume Market Share by Type (2013-2018)
    Figure Japan Biosimilar Monoclonal Antibodies Sales Volume Market Share by Type in 2017
    Table Japan Biosimilar Monoclonal Antibodies Sales Volume (K Units) by Application (2013-2018)
    Table Japan Biosimilar Monoclonal Antibodies Sales Volume Market Share by Application (2013-2018)
    Figure Japan Biosimilar Monoclonal Antibodies Sales Volume Market Share by Application in 2017
    Figure Southeast Asia Biosimilar Monoclonal Antibodies Sales (K Units) and Growth Rate (2013-2018)
    Figure Southeast Asia Biosimilar Monoclonal Antibodies Revenue (Million USD) and Growth Rate (2013-2018)
    Figure Southeast Asia Biosimilar Monoclonal Antibodies Sales Price (USD/Unit) Trend (2013-2018)
    Table Southeast Asia Biosimilar Monoclonal Antibodies Sales Volume (K Units) by Players (2013-2018)
    Table Southeast Asia Biosimilar Monoclonal Antibodies Sales Volume Market Share by Players (2013-2018)
    Figure Southeast Asia Biosimilar Monoclonal Antibodies Sales Volume Market Share by Players in 2017
    Table Southeast Asia Biosimilar Monoclonal Antibodies Sales Volume (K Units) by Type (2013-2018)
    Table Southeast Asia Biosimilar Monoclonal Antibodies Sales Volume Market Share by Type (2013-2018)
    Figure Southeast Asia Biosimilar Monoclonal Antibodies Sales Volume Market Share by Type in 2017
    Table Southeast Asia Biosimilar Monoclonal Antibodies Sales Volume (K Units) by Application (2013-2018)
    Table Southeast Asia Biosimilar Monoclonal Antibodies Sales Volume Market Share by Application (2013-2018)
    Figure Southeast Asia Biosimilar Monoclonal Antibodies Sales Volume Market Share by Application in 2017
    Figure India Biosimilar Monoclonal Antibodies Sales (K Units) and Growth Rate (2013-2018)
    Figure India Biosimilar Monoclonal Antibodies Revenue (Million USD) and Growth Rate (2013-2018)
    Figure India Biosimilar Monoclonal Antibodies Sales Price (USD/Unit) Trend (2013-2018)
    Table India Biosimilar Monoclonal Antibodies Sales Volume (K Units) by Players (2013-2018)
    Table India Biosimilar Monoclonal Antibodies Sales Volume Market Share by Players (2013-2018)
    Figure India Biosimilar Monoclonal Antibodies Sales Volume Market Share by Players in 2017
    Table India Biosimilar Monoclonal Antibodies Sales Volume (K Units) by Type (2013-2018)
    Table India Biosimilar Monoclonal Antibodies Sales Volume Market Share by Type (2013-2018)
    Figure India Biosimilar Monoclonal Antibodies Sales Volume Market Share by Type in 2017
    Table India Biosimilar Monoclonal Antibodies Sales Volume (K Units) by Application (2013-2018)
    Table India Biosimilar Monoclonal Antibodies Sales Volume Market Share by Application (2013-2018)
    Figure India Biosimilar Monoclonal Antibodies Sales Volume Market Share by Application in 2017
    Table Pfizer, Inc. Basic Information List
    Table Pfizer, Inc. Biosimilar Monoclonal Antibodies Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2013-2018)
    Figure Pfizer, Inc. Biosimilar Monoclonal Antibodies Sales Growth Rate (2013-2018)
    Figure Pfizer, Inc. Biosimilar Monoclonal Antibodies Sales Global Market Share (2013-2018)
    Figure Pfizer, Inc. Biosimilar Monoclonal Antibodies Revenue Global Market Share (2013-2018)
    Table Novartis AG Basic Information List
    Table Novartis AG Biosimilar Monoclonal Antibodies Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2013-2018)
    Figure Novartis AG Biosimilar Monoclonal Antibodies Sales Growth Rate (2013-2018)
    Figure Novartis AG Biosimilar Monoclonal Antibodies Sales Global Market Share (2013-2018)
    Figure Novartis AG Biosimilar Monoclonal Antibodies Revenue Global Market Share (2013-2018)
    Table Reliance Life Sciences Basic Information List
    Table Reliance Life Sciences Biosimilar Monoclonal Antibodies Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2013-2018)
    Figure Reliance Life Sciences Biosimilar Monoclonal Antibodies Sales Growth Rate (2013-2018)
    Figure Reliance Life Sciences Biosimilar Monoclonal Antibodies Sales Global Market Share (2013-2018
    Figure Reliance Life Sciences Biosimilar Monoclonal Antibodies Revenue Global Market Share (2013-2018)
    Table Allergan plc Basic Information List
    Table Allergan plc Biosimilar Monoclonal Antibodies Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2013-2018)
    Figure Allergan plc Biosimilar Monoclonal Antibodies Sales Growth Rate (2013-2018)
    Figure Allergan plc Biosimilar Monoclonal Antibodies Sales Global Market Share (2013-2018)
    Figure Allergan plc Biosimilar Monoclonal Antibodies Revenue Global Market Share (2013-2018)
    Table Coherus BioSciences, Inc. Basic Information List
    Table Coherus BioSciences, Inc. Biosimilar Monoclonal Antibodies Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2013-2018)
    Figure Coherus BioSciences, Inc. Biosimilar Monoclonal Antibodies Sales Growth Rate (2013-2018)
    Figure Coherus BioSciences, Inc. Biosimilar Monoclonal Antibodies Sales Global Market Share (2013-2018)
    Figure Coherus BioSciences, Inc. Biosimilar Monoclonal Antibodies Revenue Global Market Share (2013-2018)
    Table Biocon Basic Information List
    Table Biocon Biosimilar Monoclonal Antibodies Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2013-2018)
    Figure Biocon Biosimilar Monoclonal Antibodies Sales Growth Rate (2013-2018)
    Figure Biocon Biosimilar Monoclonal Antibodies Sales Global Market Share (2013-2018
    Figure Biocon Biosimilar Monoclonal Antibodies Revenue Global Market Share (2013-2018)
    Table Dr. Reddy's Laboratories Ltd. Basic Information List
    Table Dr. Reddy's Laboratories Ltd. Biosimilar Monoclonal Antibodies Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2013-2018)
    Figure Dr. Reddy's Laboratories Ltd. Biosimilar Monoclonal Antibodies Sales Growth Rate (2013-2018)
    Figure Dr. Reddy's Laboratories Ltd. Biosimilar Monoclonal Antibodies Sales Global Market Share (2013-2018)
    Figure Dr. Reddy's Laboratories Ltd. Biosimilar Monoclonal Antibodies Revenue Global Market Share (2013-2018)
    Table Boehringer Ingelheim GmbH Basic Information List
    Table Boehringer Ingelheim GmbH Biosimilar Monoclonal Antibodies Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2013-2018)
    Figure Boehringer Ingelheim GmbH Biosimilar Monoclonal Antibodies Sales Growth Rate (2013-2018)
    Figure Boehringer Ingelheim GmbH Biosimilar Monoclonal Antibodies Sales Global Market Share (2013-2018
    Figure Boehringer Ingelheim GmbH Biosimilar Monoclonal Antibodies Revenue Global Market Share (2013-2018)
    Table BioXpress Therapeutics SA Basic Information List
    Table BioXpress Therapeutics SA Biosimilar Monoclonal Antibodies Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2013-2018)
    Figure BioXpress Therapeutics SA Biosimilar Monoclonal Antibodies Sales Growth Rate (2013-2018)
    Figure BioXpress Therapeutics SA Biosimilar Monoclonal Antibodies Sales Global Market Share (2013-2018)
    Figure BioXpress Therapeutics SA Biosimilar Monoclonal Antibodies Revenue Global Market Share (2013-2018)
    Table Intas Pharmaceuticals Limited Basic Information List
    Table Intas Pharmaceuticals Limited Biosimilar Monoclonal Antibodies Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2013-2018)
    Figure Intas Pharmaceuticals Limited Biosimilar Monoclonal Antibodies Sales Growth Rate (2013-2018)
    Figure Intas Pharmaceuticals Limited Biosimilar Monoclonal Antibodies Sales Global Market Share (2013-2018)
    Figure Intas Pharmaceuticals Limited Biosimilar Monoclonal Antibodies Revenue Global Market Share (2013-2018)
    Table BIOCAD Basic Information List
    Table Genor BioPharma Co. Ltd Basic Information List
    Table Celltrion, Inc. Basic Information List
    Table Production Base and Market Concentration Rate of Raw Material
    Figure Price Trend of Key Raw Materials
    Table Key Suppliers of Raw Materials
    Figure Manufacturing Cost Structure of Biosimilar Monoclonal Antibodies
    Figure Manufacturing Process Analysis of Biosimilar Monoclonal Antibodies
    Figure Biosimilar Monoclonal Antibodies Industrial Chain Analysis
    Table Raw Materials Sources of Biosimilar Monoclonal Antibodies Major Players in 2017
    Table Major Buyers of Biosimilar Monoclonal Antibodies
    Table Distributors/Traders List
    Figure Global Biosimilar Monoclonal Antibodies Sales Volume (K Units) and Growth Rate Forecast (2018-2025)
    Figure Global Biosimilar Monoclonal Antibodies Revenue (Million USD) and Growth Rate Forecast (2018-2025)
    Figure Global Biosimilar Monoclonal Antibodies Price (USD/Unit) and Trend Forecast (2018-2025)
    Table Global Biosimilar Monoclonal Antibodies Sales Volume (K Units) Forecast by Regions (2018-2025)
    Figure Global Biosimilar Monoclonal Antibodies Sales Volume Market Share Forecast by Regions (2018-2025)
    Figure Global Biosimilar Monoclonal Antibodies Sales Volume Market Share Forecast by Regions in 2025
    Table Global Biosimilar Monoclonal Antibodies Revenue (Million USD) Forecast by Regions (2018-2025)
    Figure Global Biosimilar Monoclonal Antibodies Revenue Market Share Forecast by Regions (2018-2025)
    Figure Global Biosimilar Monoclonal Antibodies Revenue Market Share Forecast by Regions in 2025
    Figure United States Biosimilar Monoclonal Antibodies Sales Volume (K Units) and Growth Rate Forecast (2018-2025)
    Figure United States Biosimilar Monoclonal Antibodies Revenue (Million USD) and Growth Rate Forecast (2018-2025)
    Figure Europe Biosimilar Monoclonal Antibodies Sales Volume (K Units) and Growth Rate Forecast (2018-2025)
    Figure Europe Biosimilar Monoclonal Antibodies Revenue and Growth Rate Forecast (2018-2025)
    Figure China Biosimilar Monoclonal Antibodies Sales Volume (K Units) and Growth Rate Forecast (2018-2025)
    Figure China Biosimilar Monoclonal Antibodies Revenue (Million USD) and Growth Rate Forecast (2018-2025)
    Figure Japan Biosimilar Monoclonal Antibodies Sales Volume (K Units) and Growth Rate Forecast (2018-2025)
    Figure Japan Biosimilar Monoclonal Antibodies Revenue (Million USD) and Growth Rate Forecast (2018-2025)
    Figure Southeast Asia Biosimilar Monoclonal Antibodies Sales Volume (K Units) and Growth Rate Forecast (2018-2025)
    Figure Southeast Asia Biosimilar Monoclonal Antibodies Revenue (Million USD) and Growth Rate Forecast (2018-2025)
    Figure India Biosimilar Monoclonal Antibodies Sales Volume (K Units) and Growth Rate Forecast (2018-2025)
    Figure India Biosimilar Monoclonal Antibodies Revenue (Million USD) and Growth Rate Forecast (2018-2025)
    Table Global Biosimilar Monoclonal Antibodies Sales (K Units) Forecast by Type (2018-2025)
    Figure Global Biosimilar Monoclonal Antibodies Sales Volume Market Share Forecast by Type (2018-2025)
    Table Global Biosimilar Monoclonal Antibodies Revenue (Million USD) Forecast by Type (2018-2025)
    Figure Global Biosimilar Monoclonal Antibodies Revenue Market Share Forecast by Type (2018-2025)
    Table Global Biosimilar Monoclonal Antibodies Price (USD/Unit) Forecast by Type (2018-2025)
    Table Global Biosimilar Monoclonal Antibodies Sales (K Units) Forecast by Application (2018-2025)
    Figure Global Biosimilar Monoclonal Antibodies Sales Market Share Forecast by Application (2018-2025)
    Table Research Programs/Design for This Report
    Figure Bottom-up and Top-down Approaches for This Report
    Figure Data Triangulation
    Table Key Data Information from Secondary Sources
    Table Key Data Information from Primary Sources

Request sample If you need any reports sample, just let us know.